The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - Seagen
Randomized phase 2 trial of polatuzumab vedotin (pola) with bendamustine and rituximab (BR) in relapsed/refractory (r/r) FL and DLBCL.
 
Laurie Helen Sehn
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Gilead Sciences; Janssen; Lundbeck; Roche/Genentech; Seagen; TG Therapeutics
 
Manali Kamdar
No Relationships to Disclose
 
Alex Francisco Herrera
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; Merck; Pharmacyclics; Seagen
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Immune Design (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Andrew McMillan
Honoraria - Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Novartis; Roche; Sandoz
Speakers' Bureau - Roche
Research Funding - Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Celgene; Roche; Takeda
 
Christopher Flowers
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BeiGene; Celgene; Denovo Biopharma; Gilead Sciences; Karyopharm Therapeutics; OptumRx; Pharmacyclics/Janssen; Seagen; Spectrum Pharmaceuticals
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); BeiGene (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immune Design (Inst); Infinity Pharmaceuticals (Inst); Janssen Oncology (Inst); Onyx (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Genentech/Roche; Gilead Sciences
 
Won Seog Kim
No Relationships to Disclose
 
Tae Min Kim
No Relationships to Disclose
 
Muhit Özcan
Honoraria - Amgen
Speakers' Bureau - Takeda
Research Funding - Bayer (Inst); Celgene (Inst); Janssen (Inst); MSD (Inst); Novartis (Inst); Pharmacyclics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Abbvie; Abdi Ibrahim; Bristol-Myers Squibb; Celgene; Roche; Takeda
 
Judit Demeter
Consulting or Advisory Role - Acraf; Amgen; Aramis Pharma; Bristol-Myers Squibb; Novartis; Pfizer; Roche
 
Mark Hertzberg
Honoraria - Gilead Sciences; MSD; Takeda
Consulting or Advisory Role - Janssen; MSD; Roche; Takeda
Research Funding - Roche (Inst); Takeda (Inst)
 
Marek Trněný
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Gilead Sciences; Incyte; Janssen; Roche; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Gilead Sciences; Incyte; Janssen; Roche; Takeda
Travel, Accommodations, Expenses - Abbvie; Amgen; Bristol-Myers Squibb; Gilead Sciences; Incyte; janssen; Roche; Takeda
 
Gilles A. Salles
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Gilead Sciences; Gilead Sciences; Janssen; Novartis; Roche/Genentech; SERVIER
Consulting or Advisory Role - Acerta Pharma; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Kite, a Gilead company; Merck; Novartis; Novimmune; Pfizer; Roche/Genentech; SERVIER
Research Funding - Celgene; Gilead Sciences; Merck; Roche/Genentech; Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Sanofi
 
Andrew Davies
Honoraria - Gilead Sciences; Janssen; Pfizer; Roche
Consulting or Advisory Role - Celgene; Gilead Sciences; Roche; Takeda
Research Funding - Acerta Pharma (Inst); Bayer (Inst); Cancer Research Institute (Inst); Celgene (Inst); Gilead Sciences (Inst); Janssen (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Celgene; Gilead Sciences; Roche; Takeda
 
Jamie H. Hirata
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Ji Cheng
Employment - Roche
 
Grace Ku
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Matthew J. Matasar
Consulting or Advisory Role - Genentech
Research Funding - Genentech/Roche (Inst)